- Report
- January 2022
- 122 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- July 2022
- 100 Pages
Global
From €1912EUR$1,925USD£1,590GBP
€2732EUR$2,750USD£2,272GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- January 2022
- 122 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- September 2024
- 80 Pages
Japan
From €3477EUR$3,500USD£2,891GBP
From €3477EUR$3,500USD£2,891GBP
- Report
- November 2023
- 182 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 172 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 190 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 77 Pages
United States
From €3477EUR$3,500USD£2,891GBP
- Report
- August 2023
- 176 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- December 2022
- 118 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2022
- 115 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- July 2022
- 117 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- January 2022
- 204 Pages
Global
From €4471EUR$4,500USD£3,717GBP
- Report
- October 2023
- 71 Pages
Japan
From €3477EUR$3,500USD£2,891GBP
The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more